By contrast, Keystone et al. and Westhovens et al. included patients with a median disease duration of 10 years or those resistant to disease-modifying antirheumatic drugs (i.e., DMARDs), which complicated determining whether lymphoma was caused by the disease or anti-TNF-α therapy [18,19]. This evidence concerns the gene TNF and lymphoma.